Sinclair and Dexcel in UK Aloclair distribution deal

UK-based specialty drugmaker Sinclair Pharma has signed a deal with Israeli drug developer Dexcel Pharma, which will see the latter begin selling the former's mouth ulcer treatment Aloclair in the UK.

The Godalming-headquartered company explained that the product, which has until now been marketed exclusively to customers, in the future will be promoted to dental professionals. The firm said that the move is designed to drive sales, adding that the product has the highest market share in countries where a similar marketing strategy is employed.

Under the terms of the deal, Sinclair will supply Aloclair rinse, gel and spray to Dexcel, which will then be responsible for all distribution and promotion. In return, the UK firm will receive profit share payments, as well as a margin on transfer price. Financial terms of the deal were not provided.